Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Enhabit, Inc. (NYSE: EHAB) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a public issuer. Enhabit, which operates as Enhabit Home Health & Hospice, files reports with the U.S. Securities and Exchange Commission that describe its home health and hospice business, financial performance, governance matters, and executive compensation arrangements.
Through its Form 8-K filings, Enhabit reports material events such as quarterly earnings releases, participation in investor conferences, leadership changes, and stockholder meeting results. For example, the company has filed 8-Ks to furnish its earnings press releases and supplemental information for quarters ended March 31, June 30, and September 30, as well as to describe a CEO transition plan, retention awards for senior officers, and approval of the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan at its annual meeting.
Enhabit’s filings also identify its common stock as registered under Section 12(b) of the Exchange Act and traded on the New York Stock Exchange under the symbol EHAB. The company uses its SEC reports to explain its use of non-GAAP measures such as Adjusted EBITDA, Segment Adjusted EBITDA, Adjusted EPS, and Adjusted free cash flow, and to discuss how unusual or nonrecurring items affect the reconciliation to GAAP results. Same-store comparison methodology for home health and hospice locations is also described in these materials.
On this page, users can review Enhabit’s SEC filings in chronological order, including 8-Ks that detail results of operations and financial condition, regulation FD disclosures, equity plan approvals, and stockholder voting outcomes. Stock Titan’s tools surface these documents alongside AI-powered summaries that highlight key points, helping readers quickly understand how each filing relates to Enhabit’s home health and hospice operations, capital structure, and governance.
Investors and researchers can use this filings archive to follow Enhabit’s reported net service revenue trends, segment performance, executive and director arrangements, and the regulatory context around its home-based care business, all sourced from the company’s official submissions to the SEC’s EDGAR system.
Enhabit, Inc. director Barry P. Schochet reported receiving 2,382 shares of common stock on January 10, 2026. The shares were awarded at $9.97 per share and are structured as deferred stock units.
These units were taken in lieu of a cash retainer fee under the Enhabit, Inc. Deferred Director Compensation Plan. Following this transaction, Schochet beneficially owns 70,232 shares of Enhabit common stock in direct ownership.
Enhabit, Inc. director Stephan Rodgers reported receiving 1,881 shares of common stock on January 10, 2026 at a price of $9.97 per share. This was reported as an acquisition and increased his directly held position to 19,998 shares of Enhabit common stock.
According to the footnote, these 1,881 shares are deferred stock units granted in lieu of a cash retainer fee, based on his election under the Enhabit, Inc. Deferred Director Compensation Plan. This filing reflects routine director compensation paid in equity rather than cash.
Enhabit, Inc. director Mark W. Ohlendorf reported receiving 1,881 shares of common stock-equivalent deferred stock units on January 10, 2026. These units were taken instead of a cash retainer fee under the Enhabit, Inc. Deferred Director Compensation Plan, meaning the award represents routine board compensation rather than an open‑market purchase. The units were valued at a reference price of
After this grant, Ohlendorf beneficially owned 44,527 shares of Enhabit common stock in total, held directly. The filing confirms this was a single, non-derivative acquisition coded as an "A" transaction.
Enhabit, Inc. director Stuart M. McGuigan reported an acquisition of company equity as part of his board compensation. On January 10, 2026, he acquired 1,881 shares of Enhabit common stock at $9.97 per share, recorded as an "A" (acquired) transaction on a Form 4.
According to the footnote, these shares represent deferred stock units taken in lieu of a cash retainer fee under the Enhabit, Inc. Deferred Director Compensation Plan, reflecting an election to receive equity instead of cash. After this transaction, McGuigan beneficially owned 74,126 shares of Enhabit common stock, held directly.
Enhabit, Inc. director Charles M. Elson reported receiving 1,881 deferred stock units of common stock on January 10, 2026. These units were acquired at a reference price of $9.97 per share in lieu of a cash retainer fee, according to the company’s Deferred Director Compensation Plan.
After this grant, Elson beneficially owned 79,298 shares of Enhabit common stock in total, held directly. The transaction reflects routine director compensation being taken in equity rather than cash, aligning part of the director’s compensation with the company’s share performance.
Enhabit, Inc. director reports stock-based fee payment
Enhabit, Inc. director Gregory S. Rush reported receiving 2,508 shares of common stock on January 10, 2026. The transaction is coded "A," indicating an acquisition, at a reported price of $9.97 per share. After this grant, he beneficially owns 78,551 shares of Enhabit common stock in direct ownership.
The footnote explains that these 2,508 shares represent deferred stock units taken instead of a cash retainer fee under the Enhabit, Inc. Deferred Director Compensation Plan, meaning a portion of his director compensation was elected in equity rather than cash.
Enhabit, Inc. director Erin Hoeflinger reported acquiring 2,382 shares of Enhabit common stock on January 10, 2026. The shares were received as deferred stock units in lieu of a cash retainer fee, under the Enhabit, Inc. Deferred Director Compensation Plan, meaning she chose to take part of her board compensation in stock-based form instead of cash.
The transaction was coded as an acquisition at a price of $9.97 per share, and following this award she beneficially owns 78,707 shares of Enhabit common stock, held directly. This is a routine director compensation-related transaction rather than an open-market trade.
Enhabit, Inc. director Jeffrey Bolton acquired 3,761 deferred stock units on January 10, 2026, elected in lieu of a cash retainer under the Enhabit Deferred Director Compensation Plan. The units are reported as common stock at a reference price of $9.97 per share, and following this grant he beneficially owns 137,002 shares directly.
Enhabit, Inc. Chief Financial Officer reported a disposition of company common stock in a Form 4 filing. On 12/09/2025, 21,777 shares of common stock were used at a price of $9.60 per share to satisfy withholding taxes due upon the vesting of equity awards. Following this tax-withholding transaction, the reporting person beneficially owns 171,691 shares of Enhabit common stock.
Enhabit, Inc. filed a report stating that it will participate in the BofA Securities 2025 Home Care Conference on December 9, 2025, at 2:50 p.m. CT. President and CEO Barbara Jacobsmeyer and Chief Financial Officer Ryan Solomon will take part in a fireside chat.
They intend to discuss Enhabit’s strategic focus, recent business developments, and an update to anticipated pricing impacts for 2026, among other topics. An investor presentation supporting this discussion has been made available as Exhibit 99.1 and is incorporated by reference, though it is being furnished rather than filed, which limits its use for certain legal purposes.
FAQ
What is the current stock price of Enhabit (EHAB)?
What is the market cap of Enhabit (EHAB)?
